These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7700952)

  • 1. Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors.
    Planeta Cda S; Aizenstein ML; DeLucia R
    Pharmacol Biochem Behav; 1995 Jan; 50(1):35-40. PubMed ID: 7700952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reward and reinforcement produced by drinking water: role of opioids and dopamine receptor subtypes.
    Agmo A; Federman I; Navarro V; Padua M; Velazquez G
    Pharmacol Biochem Behav; 1993 Sep; 46(1):183-94. PubMed ID: 8255911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fencamfamine on latent inhibition.
    Alves CR; Delucia R; Silva MT
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1089-93. PubMed ID: 12452530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dopamine and serotonin receptor antagonists on fencamfamine-induced abolition of latent inhibition.
    de Aguiar CR; de Aguiar MJ; DeLucia R; Silva MT
    Eur J Pharmacol; 2013 Jan; 698(1-3):246-51. PubMed ID: 23123352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats.
    Ranaldi R; Beninger RJ
    Psychopharmacology (Berl); 1993; 113(1):110-8. PubMed ID: 7862816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation.
    Lisek R; Xu W; Yuvasheva E; Chiu YT; Reitz AB; Liu-Chen LY; Rawls SM
    Drug Alcohol Depend; 2012 Nov; 126(1-2):257-62. PubMed ID: 22652295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.
    Hiroi N; White NM
    Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine-induced place preference in the CXBK mouse: characteristics of mu opioid receptor subtypes.
    Suzuki T; Funada M; Narita M; Misawa M; Nagase H
    Brain Res; 1993 Jan; 602(1):45-52. PubMed ID: 8383571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fencamfamine-induced changes in the parameters of the matching law and the effect of previous exposure to the drug.
    Garcia-Mijares M; Delucia R; Silva MT
    Behav Pharmacol; 2004 Dec; 15(8):577-84. PubMed ID: 15577456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration intensifies the reinforcing effect of fencamfamine in rats.
    DeLucia R; Planeta CS; Aizenstein ML; Scavone C
    Gen Pharmacol; 1997 Aug; 29(2):265-7. PubMed ID: 9251911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinforcing effects of methamphetamine in planarians.
    Kusayama T; Watanabe S
    Neuroreport; 2000 Aug; 11(11):2511-3. PubMed ID: 10943713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pipradrol conditioned place preference is blocked by SCH23390.
    White NM; Hiroi N
    Pharmacol Biochem Behav; 1992 Oct; 43(2):377-80. PubMed ID: 1359572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D1 receptor antagonist reduces stimulant-induced conditioned place preferences and dopamine receptor supersensitivity.
    Gu SM; Cha HJ; Seo SW; Hong JT; Yun J
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Jan; 393(1):131-138. PubMed ID: 31372696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rat striatal slices.
    DeLucia R; Planeta CS; Ferreira MP; Aizenstein ML; Scavone C
    Braz J Med Biol Res; 1997 May; 30(5):637-40. PubMed ID: 9283632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists.
    Meririnne E; Kankaanpää A; Seppälä T
    J Pharmacol Exp Ther; 2001 Aug; 298(2):539-50. PubMed ID: 11454915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D1- and D2-like dopamine receptors in the CA1 region of the hippocampus are involved in the acquisition and reinstatement of morphine-induced conditioned place preference.
    Assar N; Mahmoudi D; Farhoudian A; Farhadi MH; Fatahi Z; Haghparast A
    Behav Brain Res; 2016 Oct; 312():394-404. PubMed ID: 27374160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats.
    Beninger RJ; Cheng M; Hahn BL; Hoffman DC; Mazurski EJ; Morency MA; Ramm P; Stewart RJ
    Psychopharmacology (Berl); 1987; 92(3):343-9. PubMed ID: 2957718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reward summation and the effects of dopamine D1 and D2 agonists and antagonists on fixed-interval responding for brain stimulation.
    Hunt GE; Atrens DM; Jackson DM
    Pharmacol Biochem Behav; 1994 Aug; 48(4):853-62. PubMed ID: 7972288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.